Global X Genomics & Biotechnology ETF (GNOM) News Today $10.21 -0.08 (-0.78%) (As of 11:58 AM ET) Add Compare Share Share Headlines Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period 10x Genomics Misses Revenue ForecastOctober 29, 2024 | fool.comGlobal X Genomics & Biotechnology UCITS ETF (GNOM.L)August 18, 2024 | finance.yahoo.comGNOM Global X Genomics & Biotechnology ETFJuly 25, 2024 | seekingalpha.com3 Gene Editing Stocks with the Potential to Make You an Overnight MillionaireMay 2, 2024 | investorplace.comThe Analyst Landscape: 4 Takes On 10x GenomicsApril 18, 2024 | markets.businessinsider.com3 Stocks That Could Be the Next Big Thing in Gene EditingMarch 21, 2024 | investorplace.comGlobal X Genomics & Biotechnology UCITS ETF (GNOG.L)March 14, 2024 | finance.yahoo.comGlobal X Genomics & Biotechnology ETF (GNOM)March 6, 2024 | investing.comGlobal X Cannabis ETF declares $0.1656 dividendDecember 29, 2023 | msn.comShort Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Expands By 47.6%Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Free Report) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 42,200 shares, an increase of 47.6% from the November 15th total of 28,600 shares. Based on an average daily volume of 285,600 shares, the days-to-cover ratio is presently 0.1 days.December 14, 2023 | marketbeat.comMirae Asset Global Investments Co. Ltd. Has $4.65 Million Stock Holdings in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Mirae Asset Global Investments Co. Ltd. lessened its stake in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Free Report) by 25.3% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 377,749 shares of the company's stock after sellinAugust 11, 2023 | marketbeat.comShort Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Rises By 44.8%Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Free Report) was the recipient of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 68,200 shares, an increase of 44.8% from the June 15th total of 47,100 shares. Based on an average daily trading volume, of 71,900 shares, the short-interest ratio is currently 0.9 days.July 17, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Boosts Holdings in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Raymond James Financial Services Advisors Inc. grew its stake in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Free Report) by 32.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 133,829 shares of theJuly 12, 2023 | marketbeat.comJames J. Burns & Company LLC Makes New Investment in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)James J. Burns & Company LLC bought a new stake in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 12,823 shares of the company's stock, valued aJuly 7, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Buys 13,244 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Raymond James Financial Services Advisors Inc. lifted its stake in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 15.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor oMay 28, 2023 | marketbeat.comMirae Asset Global Investments Co. Ltd. Has $6.40 Million Stock Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Mirae Asset Global Investments Co. Ltd. reduced its position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 4.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 505,607 shares of theMay 23, 2023 | marketbeat.comGlobal X S&P 500® Catholic Values ETF (CATH)May 12, 2023 | investing.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM), Quotes and News SummaryApril 29, 2023 | benzinga.comComplete Genomics Stock Falls On Unusually High Volume (GNOM)April 15, 2023 | thestreet.com15,239 Shares in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Bought by Clearwater Capital Advisors LLCClearwater Capital Advisors LLC acquired a new position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 15,239 shares of the company's stocApril 10, 2023 | marketbeat.comSightline Wealth Advisors LLC Grows Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Sightline Wealth Advisors LLC raised its position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 34.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,332 shares ofApril 6, 2023 | marketbeat.comPrivate Advisor Group LLC Sells 134,751 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Private Advisor Group LLC lessened its stake in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 11.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,073,255 shares of the company's stock afteApril 3, 2023 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Holdings Cut by McGuire Investment Group LLCMcGuire Investment Group LLC decreased its stake in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 51.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 250,194 shares ofMarch 17, 2023 | marketbeat.comMcGuire Investment Group LLC Sells 266,038 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)McGuire Investment Group LLC lowered its holdings in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 51.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 250,194 shares of thMarch 17, 2023 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Sees Significant Decline in Short InterestGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) saw a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 33,200 shares, a decline of 61.4% from the February 13th total of 86,100 shares. Based on an average daily volume of 103,000 shares, the short-interest ratio is presently 0.3 days.March 10, 2023 | marketbeat.comUBS Group AG Sells 24,463 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)UBS Group AG reduced its stake in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 14.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 139,223 shares of the company's stock after sellMarch 9, 2023 | marketbeat.comMML Investors Services LLC Sells 8,782 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)MML Investors Services LLC reduced its holdings in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 14.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 52,942 shares of the company's sMarch 6, 2023 | marketbeat.comNomura Asset Management Co. Ltd. Acquires 49,700 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Nomura Asset Management Co. Ltd. grew its holdings in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 49,700.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 49,800 shares ofFebruary 23, 2023 | marketbeat.comGlobal X Adaptive U.S. Risk Management ETF (ONOF): January 2023 ReportFebruary 16, 2023 | benzinga.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Sold by Banco Santander S.A.Banco Santander S.A. cut its position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 36.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,800 shareFebruary 3, 2023 | marketbeat.comGNOM: Get Exposure To The Latest Genomics And Biotechnology CompaniesJanuary 18, 2023 | seekingalpha.comComplete Genomics Launches Full Sequencing Platforms at Biotech Showcase™ 2023January 10, 2023 | markets.businessinsider.comGlobal X Adaptive U.S. Risk Management ETF (ONOF): November ReportJanuary 6, 2023 | benzinga.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Sees Large Increase in Short InterestGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) saw a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 47,300 shares, an increase of 48.3% from the October 31st total of 31,900 shares. Based on an average daily trading volume, of 100,400 shares, the days-to-cover ratio is currently 0.5 days.December 3, 2022 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 55.8% in OctoberGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) saw a large drop in short interest in October. As of October 31st, there was short interest totalling 31,900 shares, a drop of 55.8% from the October 15th total of 72,100 shares. Based on an average trading volume of 110,400 shares, the days-to-cover ratio is presently 0.3 days.November 11, 2022 | marketbeat.comA Preview Of Singular Genomics Systems's EarningsNovember 4, 2022 | benzinga.comHow To Invest In Genomics And ImmunologyOctober 19, 2022 | seekingalpha.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 60.7% in SeptemberGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 110,000 shares, a drop of 60.7% from the September 15th total of 279,900 shares. Based on an average daily trading volume, of 108,400 shares, the short-interest ratio is presently 1.0 days.October 13, 2022 | marketbeat.com10x Genomics: No Signs Of A Growth Turnaround, Heavy Bearish MomentumOctober 12, 2022 | seekingalpha.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Sees Significant Increase in Short InterestGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) was the target of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 279,900 shares, a growth of 232.0% from the August 31st total of 84,300 shares. Based on an average daily trading volume, of 129,600 shares, the days-to-cover ratio is currently 2.2 days.September 28, 2022 | marketbeat.comESMO 2022: REVEAL GENOMICS®️ PRESENTS NEW VALIDATION DATA OF HER2DX®️ IN THE PerELISA TRIALSeptember 12, 2022 | yahoo.comGlobal Optical Genome Mapping Market 2022-2027: Featuring Key Players Bionano Genomics, Nabsys, France Genomique & OthersAugust 8, 2022 | benzinga.comShort Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Declines By 23.2%Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) was the target of a large decrease in short interest in July. As of July 15th, there was short interest totalling 164,400 shares, a decrease of 23.2% from the June 30th total of 214,100 shares. Based on an average daily volume of 203,400 shares, the days-to-cover ratio is currently 0.8 days.August 1, 2022 | marketbeat.comWhat 5 Analyst Ratings Have To Say About 10x GenomicsJuly 15, 2022 | benzinga.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Up 56.0% in JuneGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) saw a large growth in short interest in June. As of June 15th, there was short interest totalling 63,500 shares, a growth of 56.0% from the May 31st total of 40,700 shares. Based on an average daily volume of 169,000 shares, the short-interest ratio is currently 0.4 days.July 2, 2022 | marketbeat.comNIH's National Human Genome Research Institute and NSTA Unveil New Genome: Unlocking Life's Code Educational Resources for EducatorsJune 16, 2022 | benzinga.comUltima Genomics Collaborates with NVIDIA To Deliver $100 Genome Sequencing with AI and Accelerated ComputingJune 6, 2022 | markets.businessinsider.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 44.2% in MayGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) was the recipient of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 39,600 shares, a drop of 44.2% from the April 30th total of 71,000 shares. Based on an average daily volume of 179,700 shares, the short-interest ratio is presently 0.2 days.May 28, 2022 | marketbeat.comSightline Wealth Advisors, LLC Buys iShares 0-5 Year TIPS Bond ETF, ARK Genomic Revolution ETF,January 26, 2022 | finance.yahoo.comSightline Wealth Advisors, LLC Buys iShares 0-5 Year TIPS Bond ETF, ARK Genomic Revolution ETF, ...January 26, 2022 | finance.yahoo.com Get Global X Genomics & Biotechnology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover GNOM Media Mentions By Week GNOM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNOM News Sentiment▼0.430.91▲Average News Sentiment GNOM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNOM Articles This Week▼00▲GNOM Articles Average Week Get Global X Genomics & Biotechnology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Tema Cardiovascular and Metabolics ETF News Today Tradr 2X Long Innovation ETF News Today Global X Data Center & Digital Infrastructure ETF News Today Global X E-Commerce ETF News Today Spear Alpha ETF News Today Tradr 2X Short Innovation Daily ETF News Today Global X Video Games & Esports ETF News Today Roundhill GLP-1 & Weight Loss ETF News Today Procure Space ETF News Today First Trust Dow Jones International Internet ETF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNOM) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts